Confounding factors for early death in incident end-stage renal disease patients: Role of emergency dialysis start

Hemodialysis International

Volumn 15, Issue 1, 2011, Pages 23-29

  Descamps, Chrystèle ^a   Labeeuw, Michel ^a,b   Trolliet, Pierre ^a   Cahen, Rémi ^a   Ecochard, René ^b,c   Pouteil Noble, Claire ^a,b   Villar, Emmanuel ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

Emergency dialysis start; End stage renal disease; Hemodialysis; Mortality; Peritoneal dialysis; Prevention

Indexed keywords

ADULT; ARTICLE; CENTRAL VENOUS CATHETER; COMORBIDITY; CONFOUNDING VARIABLE; DEATH; DIALYSIS; FEMALE; HAZARD RATIO; HEART FAILURE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; RISK FACTOR; SURVIVAL; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPLICATION; HEMODIALYSIS; MIDDLE AGED; PERITONEAL DIALYSIS; PROCEDURES; PROSPECTIVE STUDY;

COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 79251579292     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2010.00513.x     Document Type: Article

References (27)

1. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: What do they tell us? Kidney Int. 2006; 103 (Suppl):S3-S11.
2. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol. 2009; 20:155-163.
3. Winkelmayer WC, Glynn RJ, Mittleman MA, et al. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: A propensity score approach. J Am Soc Nephrol. 2002; 13:2353-2362.
4. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int. 2003; 64:1071-1079.
5. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004; 66:2389-2401.
6. Murphy SW, Foley RN, Barrett BJ, et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int. 2000; 57:1720-1726.
7. Jaar BG, Coresh J, Plantinga LC, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med. 2005; 143:174-183.
8. Noordzij M, Korevaar JC, Bos WJ, et al. Mineral metabolism and cardiovascular morbidity and mortality risk: Peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant. 2006; 21:2513-2520.
9. Termorshuizen F, Korevaar JC, Dekker FW, et al. Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis. J Am Soc Nephrol. 2003; 14:2851-2860.
10. Kessler M, Frimat L, Panescu V, Briançon S. Impact of nephrology referral on early and midterm outcomes in ESRD: EPidémiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis. 2003; 42:474-485.
11. Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003; 41:310-318.
12. Couchoud C, Moranne O, Frimat L, et al. Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease. Nephrol Dial Transplant. 2007; 22:3246-3254.
13. Astor BC, Eustace JA, Powe NR, et al. Type of vascular access and survival among incident hemodialysis patients: The choices for healthy outcomes in caring for ESRD (CHOICE) study. J Am Soc Nephrol. 2005; 16:1449-1455.
14. Villar E, Rabilloud M, Berthoux F, et al. A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes. Nephrol Dial Transplant. 2004; 19:207-214.
15. Karamé A, Labeeuw M, Trolliet P, et al. The impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders. Nephron Clin Pract. 2009; 112:c268-c275.
16. Schoenfeld DA, Richter JR. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics. 1982; 38:163-170.
17. Bagshaw SM. Short- and long-term survival after acute kidney injury. Nephrol Dial Transplant. 2008; 23:2126-2128.
18. Couchoud C, Stengel B, Jacquelinet C. REIN annual report 2005. Renal epidemiology and information network & agence de la biomédecine. Nephrol Ther. 2007; 3 (Suppl 1):S1-S82.
19. Villar E, Frimat L, Ecochard R, Labeeuw M. Specifities of the methodology of survival analysis in dialysis patients. Nephrol Ther. 2008; 4:553-561.
20. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994; 81:515-526.
21. Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM. Predictors of central venous catheter use at the initiation of hemodialysis. Semin Dial. 2008; 21:346-351.
22. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: A propensity score analysis. J Am Soc Nephrol. 2004; 15:477-486.
23. Polkinghorne KR, Seneviratne M, Kerr PG. Effect of a vascular access nurse coordinator to reduce central venous catheter use in incident hemodialysis patients: A quality improvement report. Am J Kidney Dis. 2009; 53:99-106.
24. Couchoud C, Savoye E, Frimat L, et al. Variability in case mix and peritoneal dialysis selection in fifty-nine French districts. Perit Dial Int. 2008; 28:509-517.
25. Stack AG. Determinants of modality selection among incident US dialysis patients: Results from a national study. J Am Soc Nephrol. 2002; 13:1279-1287.
26. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies-An international review: Costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant. 1999; 14 (Suppl 6):31-41.
27. Schiffrin El, Lipman ML, Mann JF. Chronic kidney disease: Effects on the cardiovascular system. Circulation. 2007; 116:85-97.